Table 4

 Demographic and clinical characteristics of groups according to genotype*

Genotype I–II/I–II(n = 37)Genotype I–II/III, IV or V(n = 37)p value
BMI, body mass index.
*Data obtained at the first visit to adult unit.
Sex (no (%) male)18 (48.6%)22 (59.5%)0.484
Mean (SD) age (years)22.5 (4.9)30.9 (8.8)<0.001
Mean (SD) age at diagnosis (years)4.2 (5.3)21.9 (13.4)<0.001
Adult age at diagnosis, n (%)1 (2.7%)28 (75.7%)<0.001
Mean (SD) follow up (years)3.7 (3.7)5.3 (1.9)0.024
Mean (SD) BMI (kg/m2)18.4 (2.9)23 (3)<0.001
Mean (SD) sweat chloride concentration (mEq/l)108 (23)89 (22)0.001
Digestive symptoms at diagnosis, n (%)28 (73.7%)9 (24.3%)0.010
Pancreatic insufficiency, n (%)36 (97.3%)9 (24.3%)<0.001
Pulmonary symptoms at diagnosis, n (%)25 (68.4%)28 (75.7%)0.439
P aeruginosa colonisation, n (%)32 (86.5%)16 (43.2%)<0.001
S aureus colonisation, n (%)22 (59.5%)12 (32.4%)0.019
End-stage lung disease, n (%)15 (40.5%)1 (2.7%)0.001
Lung transplantation, n (%)9 (24.3%)1 (2.7%)0.010
Dead patients, n (%)11 (29.7%)1 (2.4%)0.012